ArticlePediatric cardiology2026
Beyond Body Mass Index: Skeletal Muscle Mass as a Marker of Physiologic Reserve in Fontan Circulation.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Body mass index (BMI) incompletely captures body composition and functional reserve in congenital heart disease. We assessed whether skeletal muscle mass (SMM) relates more closely than BMI to stroke volume (SV), strength, and peak oxygen uptake (VO₂max) in Fontan physiology versus healthy controls. Cross-sectional assessment included multifrequency bioimpedance SMM, noninvasive SV (NICaS), handgrip dynamometry, and cardiopulmonary exercise testing. Associations of SMM and BMI with SV, grip strength, and VO₂max were evaluated within cohorts using Pearson correlations, and impedance SMM was compared with Lee-equation SMM. Forty-two participants were studied: Fontan group (n = 21; mean age 28.3 ± 9.7 years; 8 women) and control group (n = 21; mean age 29.5 ± 5.9 years; 7 women). BMI was lower in the Fontan group than in the control group (24.0 ± 4.4 vs. 26.4 ± 3.4 kg/m²), as was SMM (27.8 ± 6.2 vs. 34.0 ± 7.7 kg). SMM correlated with SV in the control group (r = 0.770, p < 0.0001) and Fontan group (r = 0.573, p = 0.007), whereas BMI showed a weaker association in the control group (r = 0.465, p = 0.034) and no significant association in the Fontan group (r = 0.365, p = 0.104). SMM correlated with handgrip strength in both groups (control r = 0.754; Fontan r = 0.807), whereas BMI did not (controls r = 0.197; Fontan r = 0.242). SMM correlated with VO₂max in the control group (r = 0.503, p = 0.020), but not in the Fontan group (r = 0.106, p = 0.65). BMI correlated with SMM in the control group (r = 0.448, p = 0.042), but not in the Fontan group (r = 0.361), suggesting greater body composition heterogeneity in Fontan patients. Impedance-derived and Lee-estimated skeletal muscle mass showed strong agreement in both groups (control r = 0.903; Fontan r = 0.864). SMM outperformed BMI in reflecting SV and strength; in Fontan circulation, VO₂max appears more centrally constrained than muscle-mass limited.
Indexed as
Identifiers
42371049What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.